Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction for the Development of Metachronous Gastric Cancer After Endoscopic Submucosal Dissection by Serum Pepsinogen

NCT02682446 is registered in ClinicalTrials.gov with Kyungpook National University Hospital as lead sponsor.

NCT NCT02682446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction for the Development of Metachronous Gastric Cancer After Endoscopic Submucosal Dissection by Serum Pepsinogen
Lead sponsor
Kyungpook National University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2015
Enrollment
800 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer